Jefferies initiated Viking Therapeutics (NASDAQ: VKTX) with a Buy rating and $110 per share price target in a note Thursday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change Hot List New Coverage

Midday movers: Victoria's Secret, Nordstrom fall; OneSpan, Novo Nordisk riseMarch 7, 2024 8:08 AM Viking Therapeutics (VKTX), Lilly (LLY) Edge Lower Following Novo (NVO) Obesity DataMarch 7, 2024 7:23 AM Novo valuation surpasses Tesla on experimental obesity drug dataMarch 7, 2024 2:50 AM Jefferies Starts Viking Therapeutic (VKTX) at Buy, 'Strong Mid-Stage Obesity Player with Scarcity Value'March 7, 2024 1:58 AM